Ad hoc: Celesio AG: Celesio AG acquires majority stake in DocMorris

Thursday, 26. April 2007 10:20



Stuttgart, 26 April 2007 - Today the Supervisory Board of Celesio AG
has approved the share purchase agreement on the acquisition of circa
90% of the share capital of WWMW e-commerce international GmbH, the
holding company of the DocMorris-group. The remaining circa 10% of
the share capital are being held by the management of DocMorris.
Through this acquisition Celesio gets hold of the only pharmacy brand
which is known all over Germany. By doing so, Celesio sets a clear
signal against discounters and both national and international
interested parties without a traditional relation to the pharmacy
business. At the same time, Celesio establishes the basis for
strengthening the market position of the customers of its German
subsidiary GEHE. DocMorris will remain legally independent within the
Celesio-group. The acquisition is subject to clearance by the German
Competition Council (Bundeskartellamt).

Celesio AG
Neckartalstraße 155
70376 Stuttgart
Germany

Contact: Rainer Berghausen +49.711.5001-549

End of ad-hoc release.

WKN: CLS 100; ISIN: DE000CLS1001
Indices: CDAX, MDAX, Prime All Share, CLASSIC All Share, HDAX, MIDCAP
Listed: Official market in Berlin-Bremen, Düsseldorf, Francfurt
(Prime Standard), Munich, Stuttgart; unofficial regulated market in
Hamburg and Hanover



--- End of Message ---

Celesio AG
Neckartalstrasse 155 Stuttgart Germany

WKN: CLS100;
ISIN: DE000CLS1001; Index: CDAX, MDAX, Prime All Share, CLASSIC All
Share, HDAX, MIDCAP;
Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime
Standard in Frankfurter Wertpapierbörse,
Amtlicher Markt in Bayerische Börse München, Amtlicher Markt in Börse
Düsseldorf,
Amtlicher Markt in Börse Stuttgart, Freiverkehr in Hanseatische
Wertpapierbörse zu Hamburg,
Freiverkehr in Niedersächsische Börse zu Hannover, Amtlicher Markt in
Börse Berlin Bremen;
Related Links: McKesson Europe AG
Author:
Hugin
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.